National Institute of General Medical Sciences

Clarkson University Team Awarded Grant to Support North Country High School Students’ interest in Clinical Neuroscience

Retrieved on: 
Monday, October 2, 2023
Online, Concussion, SEPA, Next Generation Science Standards, Psychology, Clarkson University, Curriculum, National Institute of General Medical Sciences, Science, technology, engineering, and mathematics, Research, Mentorship, Clarkson, Bangladesh Technical Education Board, Student, Achievement Medal, Princeton University Department of Psychology, Earl, Outline of health sciences, Teacher, Faculty, Health, NIH, Education, Computer science and engineering, Nursing, Science, Mathematics, Engineering

This  program is designed to address key, modifiable barriers that limit student interest in and the ability to succeed in health care careers.

Key Points: 
  • This  program is designed to address key, modifiable barriers that limit student interest in and the ability to succeed in health care careers.
  • BRAIN-STEM provides local 9th–12th grade students and high school teachers, with five-day summer camps and an afterschool program to explore neuroscience.
  • Key to the success of the program includes Clarkson undergraduate students who serve as near-peer mentors and role models to high school participants.
  • This widely disseminated work will allow the North Country to be on the forefront of educating future healthcare professionals.

Assistant Professor of Biology Awarded Nearly $1.8 Million Research Award by the National Institutes of Health

Retrieved on: 
Tuesday, September 26, 2023
Tissue, Human, Clarkson University, Hunting, National Institute of General Medical Sciences, Research, Mentorship, Cell, Fruit, Bangladesh Technical Education Board, Student, MIRA, Disease, Pharmaceutical industry, Management, NIGMS, Biology

Potsdam, NY, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Ginger Hunter, an assistant professor of Biology at Clarkson University, has been awarded a Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators from the National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health.

Key Points: 
  • Potsdam, NY, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Ginger Hunter, an assistant professor of Biology at Clarkson University, has been awarded a Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators from the National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health.
  • The nearly $1.8 million grant began August 2023 and will last for five years.
  • Cells in these tissues usually start off unorganized, but during development become organized due to cell-cell communication events across large and small distances.
  • Defects in cell-cell communication during patterning can lead to human disorders and disease.

Daxor Corporation Awarded $305K Grant from the National Institutes of Health to Develop Blood Volume Guidance Software in Sepsis Patients

Retrieved on: 
Monday, September 11, 2023
Sepsis, SBIR, National Institute of General Medical Sciences, Bangladesh Technical Education Board, Fluid, Small Business Innovation Research, Death, Patient, Blood volume, NIGMS, NIH, Pharmaceutical industry, Medical imaging

Oak Ridge, TN, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announced that the National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) has awarded the Company a $305K Phase I Small Business Innovative Research (SBIR) grant to support the development of the Sepsis FLO (Sepsis Fluid Optimizer), a clinical decision support tool designed to precisely guide blood volume management and treatment in sepsis patients.

Key Points: 
  • Oak Ridge, TN, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announced that the National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) has awarded the Company a $305K Phase I Small Business Innovative Research (SBIR) grant to support the development of the Sepsis FLO (Sepsis Fluid Optimizer), a clinical decision support tool designed to precisely guide blood volume management and treatment in sepsis patients.
  • “Sepsis impacts 1.7 million Americans annually, leading to 270,000 deaths and $62 billion in costs,” said Michael Feldschuh, CEO and President of Daxor Corporation.
  • “There is a significant unmet need for a rapid bedside test with a clinically validated sepsis fluid guidance support tool based on precise, objective assessment of circulating blood volume.
  • “The development of a clinical decision-support system will help clinicians translate blood volume analysis results into actionable treatment decisions.”

Inspiring the Next Generation of Veterinary Professionals

Retrieved on: 
Thursday, September 7, 2023
Heart, Learning, SEPA, Education, Louisiana State University, Oregon State University, Veterinarian, Public, Veterinary medicine, Hospital, Anatomy, League, Raptor, Research, Banfield Pet Hospital, PAWS Chicago, Black, VCA Animal Hospitals, Purpose, Government, Purdue University College of Pharmacy, National Institute of General Medical Sciences, Bangladesh Technical Education Board, Auburn University, Auburn University College of Architecture, Design, and Construction, Student, Animal, Laboratory, Shelby, Associate, Dog, Pet, Cattle, PETS, STEM, MPH, VCA, Nursing, Mars, DVM

NEWARK, N.J., Sept. 7, 2023 /PRNewswire/ -- In support of its Purpose—A BETTER WORLD FOR PETS®—Mars Veterinary Health is investing in several youth-centered programs to help address profession-wide talent shortages. 

Key Points: 
  • That's why Mars is committed to inspiring and supporting youth in a variety of ways, including limiting the financial burden of veterinary education.
  • Mars believes it's never too early to support passionate future veterinary professionals, and these are a few of the ways its veterinary businesses are working to help pet-loving youth pursue lifelong veterinary careers.
  • Veterinary team members interacted with students to help them learn about a career in veterinary medicine, with the goal of instilling a sense of belonging through a variety of experiences, so children can visualize themselves as veterinary professionals and eventually explore veterinary careers.
  • With programs across its family of businesses working to provide opportunities for the next generation of veterinary professionals, Mars is committed to having a positive impact on the veterinary profession.

Childhood Anxiety Detection Breakthrough: EEG Analysis Can Detect Risk for Anxiety Disorders in Children by Seven Years Old

Retrieved on: 
Thursday, August 3, 2023
Harvard Graduate School of Education, Koret Foundation, Laboratory, University, Pediatrics, Boston Children's Hospital, Frontiers, USF, National Institute of Mental Health, Anxiety, ADHD, Mental health, National Institute of General Medical Sciences, Biomarker, Doctor of Philosophy, Harvard Medical School, Health informatics, DSM-IV codes, University of San Francisco, Behavioural sciences, Risk, SAN, EEG, Faculty, Cognitive neuroscience, Hospital, AI, Education, Medicine, Nursing, Psychiatry

SAN FRANCISCO, Aug. 3, 2023 /PRNewswire-PRWeb/ -- A newly published study in the journal Frontiers in Psychiatry titled 'A biomarker discovery framework for childhood anxiety' suggests that latent factors extracted from electroencephalogram (EEG) recordings in childhood are promising candidate biomarkers for anxiety disorders and for externalizing disorders. This study found that appropriate age was important - with accuracy improving up to seven years of age for anxiety and three to five years of age for externalizing disorders (primarily ADHD). The study also suggests that anxiety emerges later than some other neurodevelopmental disorders.

Key Points: 
  • SAN FRANCISCO, Aug. 3, 2023 /PRNewswire-PRWeb/ -- A newly published study in the journal Frontiers in Psychiatry titled 'A biomarker discovery framework for childhood anxiety' suggests that latent factors extracted from electroencephalogram (EEG) recordings in childhood are promising candidate biomarkers for anxiety disorders and for externalizing disorders.
  • This study found that appropriate age was important - with accuracy improving up to seven years of age for anxiety and three to five years of age for externalizing disorders (primarily ADHD).
  • "Our study shows that EEG recordings contain information about brain function that is useful for early detection of childhood anxiety disorders, creating new opportunities for early detection and intervention.
  • With childhood anxiety disorders on the rise, these findings come at a critical time."

New RNA-based Therapy Combats Melanoma in Mouse Models; Experimental approach that triggers a type of immune cell may be beneficial against cancers in humans

Retrieved on: 
Thursday, July 27, 2023
Ohio State University, B-cell lymphoma, Icahn School of Medicine at Mount Sinai, Neoplasm, Genomics, COVID-19, State university system, Cancer, National Institute of General Medical Sciences, Icahn Genomics Institute, Mount Sinai, Cell, RNA, Doctor of Philosophy, Associate, National Cancer Institute, Dendritic cell, Patient, Melanoma, DOI, Marc, Mouse, Nature Nanotechnology, Recurrence, B cell, Breast cancer, Vaccine, Pharmaceutical industry

NEW YORK, July 27, 2023 /PRNewswire-PRWeb/ -- Investigators at the Icahn School of Medicine at Mount Sinai have designed an innovative RNA-based strategy to activate dendritic cells—which play a key role in immune response—that eradicated tumors and prevented their recurrence in mouse models of melanoma.

Key Points: 
  • Cancer cells employ strategies to switch off various stages of the cancer-immunity cycle, the process by which dendritic cells educate T cells to kill cancer cells.
  • Their investigations revealed encouraging results, as the regimen reduced tumors in mouse models of B cell lymphoma by 83 percent.
  • They also tested it in mouse models of breast cancer, where approximately half of the mice favorably responded.
  • The study was funded in part by National Cancer Institute grant P30 CA016058 and National Institute of General Medical Sciences grant R35GM144117.

NIH Awards Prenosis With Two Grants Totaling $4.8 million to Enable Precision Medicine for Sepsis

Retrieved on: 
Wednesday, July 12, 2023
Infection, Partnership, Society, Housing, Biomedical Advanced Research and Development Authority, Sepsis, Society of Critical Care Medicine, EMR, SBIR, TED (conference), National Institute of General Medical Sciences, Research, Electronic health record, Biomarker, American Thoracic Society, Development, Death, Hospital, Collection, Patient, Data, Machine learning, Algorithm, Medicine, Artificial intelligence, Biosafety, Biology, Mortality, American Association for Clinical Chemistry, WHO, NIGMS, BARDA, Medtech, NIH, MDDI, National Institutes of Health Clinical Center, Critical Care Medicine (journal), Pharmaceutical industry, Medical imaging, Nursing

CHICAGO, July 12, 2023 /PRNewswire/ -- Prenosis, Inc., an artificial intelligence company enabling precision medicine in acute care, announced today that it has been awarded two Phase 2 SBIR grants totaling $4.8M in funding by the National Institute of General Medical Sciences (NIGMS), a division of the National Institute of Health (NIH). The grants will study the use of Prenosis's Immunix™ Artificial Intelligence platform for acute immune states. Prenosis has built a collection of artificial intelligence algorithms, broad clinical data, deep biological data, and biobanked samples of patients suspected of sepsis, in addition to detailed information about their treatment regime. The goal is to better understand how patients' health states rapidly evolve in acute care environments.

Key Points: 
  • Prenosis has built a collection of artificial intelligence algorithms, broad clinical data, deep biological data, and biobanked samples of patients suspected of sepsis, in addition to detailed information about their treatment regime.
  • The goal is to better understand how patients' health states rapidly evolve in acute care environments.
  • The outcomes of these studies could usher in a new era of predictive diagnostics, clinical decision support tools, improved clinical trials, and precision medicine drugs for sepsis.
  • Prenosis generates deep biological profiles of each patient by measuring critical sepsis biomarkers in its Biological Safety Level 2 lab in Chicago.

Killer Snails Launches Immersive Environmental Science Curriculum Supplement for Grades 3-5

Retrieved on: 
Tuesday, June 13, 2023
Learning, Student, Wildlife Conservation Society, WebXR, Next Generation Science Standards, Atmosphere, Water pollution, Environmental justice, Water quality, Snail, Environmental health, Environmental education, Connections, MBA, Research, Waterway, Bangladesh Technical Education Board, Computer, Science, Tablet, Wildlife, Water, Icahn School of Medicine at Mount Sinai, National Institute of General Medical Sciences, Knowledge, Organizational founder, Ecology, Community engagement, Health, Hudson River, Environment, AR, Management, Nursing, Medicine

NEW YORK, June 13, 2023 /PRNewswire/ -- Killer Snails launched WaterWays, an innovative 3rd-5th grade science curriculum supplement focused on water ecology and environmental health.

Key Points: 
  • NEW YORK, June 13, 2023 /PRNewswire/ -- Killer Snails launched WaterWays, an innovative 3rd-5th grade science curriculum supplement focused on water ecology and environmental health.
  • Killer Snails is a small, woman and minority-owned business that creates award-winning, immersive game-based science learning experiences.
  • Founded by a scientist, an educational psychologist, and an MBA, the goal of the company is to inspire a love of science in students.
  • WaterWays was supported by the National Institute of General Medical Science of the National Institutes of Health under award number R44GM139577.

Metrodora Institute Launches to Advance the Treatment of Complex Neuroimmune Diseases and Accelerate the Path to Cures

Retrieved on: 
Wednesday, April 19, 2023
Infection, Allergy, Medicine, MSU, Therapy, Montana State University, Doctor of Philosophy, Genetics, Gastrointestinal tract, ME/CFS, Connective tissue, COVID-19, Clinical trial, DSM-IV codes, NIH, National Institute of General Medical Sciences, POTS, Postural orthostatic tachycardia syndrome, Research, COVID, SALT, Fatigue, MD, Patient, Biobank, Blood, Immune system, Pain management, Conditional sentence, Diagnosis, Entrepreneurship, MIRA, Ecosystem, Neuroimmune system, Neurology, Nursing, Pharmaceutical industry, Medical imaging, Medical device, Instacart, Metrodora

SALT LAKE CITY, April 19, 2023 /PRNewswire/ -- The Metrodora Institute today announced the opening of its state-of-the-art medical and research center, dedicated to advancing care and accelerating the path to improved diagnostics, therapeutics, and cures for patients living with neuroimmune axis disorders. The opening follows a soft launch that welcomed initial patients over the last month. Located in Salt Lake City, UT, the multidisciplinary institute brings together world-class clinicians, scientists, and engineers under one roof to maximize the impact of scientific discovery and rapidly translate research into better patient outcomes. Metrodora is designed to deliver a new blueprint for healthcare that breaks down the barriers between medical specialties and embeds scientific research and discovery directly into the patient care process. The Metrodora Foundation, the Institute's non-profit research arm, will fund and further the scientific discovery needed to accelerate novel treatments and cures.

Key Points: 
  • The Metrodora Foundation, the Institute's non-profit research arm, will fund and further the scientific discovery needed to accelerate novel treatments and cures.
  • Neuroimmune axis disorders are complex chronic illnesses that trigger dysfunctional interactions across multiple body systems, including the nervous, immune, endocrine, and gastrointestinal systems.
  • "In order to improve the lives of people living with neuroimmune axis disorders, we must accelerate progress towards treatments and cures.
  • The Metrodora Institute is bridging these gaps in care by redefining how research and clinical practice work together to treat and cure complex, chronic diseases.

30 Technology’s Clinically Validated Antimicrobial Nitric Oxide Platform Acquired by Convatec Group Plc for Several Applications

Retrieved on: 
Wednesday, April 19, 2023
Infection, COPD, Social work, LSE, Research and development, Therapy, Powder, CTEC, Stifel, Respiratory disease, Nitric oxide, Health, Immunity, Research, Cystic fibrosis, National Institute of General Medical Sciences, IP, Fungus, Sale, CN v Secretary of State for Health and Social Care, Divestment, NO, Patent, Patient, Ophthalmology, Convatec, Bacteria, NHS, Burns, Rare, Scottish Enterprise, Virus, Dentistry, Pharmaceutical industry, Vaccine, Bronchiectasis

London, UK, 19 April 2023 – 30 Technology, the world leader in clinical nitric oxide generation technology for health care, today announced that it has completed the sale of its antimicrobial nitric oxide platform in certain applications to Convatec Group Plc (LSE: CTEC).

Key Points: 
  • London, UK, 19 April 2023 – 30 Technology, the world leader in clinical nitric oxide generation technology for health care, today announced that it has completed the sale of its antimicrobial nitric oxide platform in certain applications to Convatec Group Plc (LSE: CTEC).
  • As part of the transaction, a small team from 30 Technology will transfer across to Convatec.
  • Syd Hanna, Group Executive Director of 30 Technology commented: “This transaction validates 30 Technology’s transformational approach to unlock the potential of nitric oxide to treat a range of infections with a durable and safe treatment.
  • Stifel acted as financial advisor and Goodwin Procter provided legal counsel to 30 Technology.